Severe fetal and neonatal hyperthyroidism years after surgical treatment of maternal Graves’ disease

References

• Achiron R, Rotstein Z, Lipitz S et al. 1998. The development of the foetal thyroid: in utero ultrasonographic measurements. Clinical Endocrinology 48:259–264.
   PubMed Web of Science ®Google Scholar
• Boelaert K. 2010. Treatment of Graves’ disease with antithyroid drugs: current perspectives. Thyroid 20:943–946.
   PubMedGoogle Scholar
• Bruinse HW, Vermeulen-Meiners C, Wit JM. 1988. Fetal treatment for thyrotoxicosis in non-thyrotoxic pregnant women. Fetal Therapy 3: 152–157.
   PubMedGoogle Scholar
• Cheron RG, Kaplan MM, Larsen PR et al. 1981. Neonatal thyroid function after propylthiouracil therapy for maternal Graves’ disease. New England Journal of Medicine 304:525–528.
   PubMed Web of Science ®Google Scholar
• Clavel S, Madec A-M, Bornet H et al. 1990. Anti TSH-receptor antibodies in pregnant patients with autoimmune thyroid disorder. British Journal of Obstetrics and Gynaecology 97:1003–1008.
   PubMedGoogle Scholar
• Cooper DS, Rivkees SA. 2009. Putting propylthiouracil in perspective. Journal of Clinical Endocrinology and Metabolism 94:1881–1882.
   PubMed Web of Science ®Google Scholar
• Cove DH, Johnston P. 1985. Fetal hyperthyroidism: experience of treatment in four siblings. Lancet 1:430–432.
   PubMedGoogle Scholar
• Daffos F, Capella-Pavlovsky M, Forestier F. 1985. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. American Journal of Obstetrics and Gynecology 153:655–660.
   PubMed Web of Science ®Google Scholar
• Daneman D, Howard NJ. 1980. Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. Journal of Pediatrics 97:257–259.
   PubMedGoogle Scholar
• Devlieger H, Martens G, Bekaert A et al. 2000. Standaarden van geboortegewicht-voor-zwangerschapsduur voor de Vlaamse boreling. Tijdschrift Geneesk 56:1–14 (Dutch).
   Google Scholar
• de Zegher F, Pernasetti F, Vanhole C et al. 1995. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. Journal of Clinical Endocrinology and Metabolism 80:3127–3130.
   PubMed Web of Science ®Google Scholar
• Gardiner-Hill H. 1929. Pregnancy complicating simple goiter and Graves’ disease. Lancet 66:132–133.
   Google Scholar
• Gardner DF, Cruikshank DP, Hays PM et al. 1986. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. Journal of Clinical Endocrinology and Metabolism 62:217–220.
   PubMed Web of Science ®Google Scholar
• Goldstein I, Lockwood C, Belanger K et al. 1988. Ultrasonographic assessment of gestational age with the distal femoral and proximal tibial ossification centers in the third trimester. American Journal of Obstetrics and Gynecology 158:127–130.
   PubMedGoogle Scholar
• Golombek SG, LaGamma EF, Paneth N. 2002. Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice. Journal of Perinatology 22:563–565.
   PubMedGoogle Scholar
• Hatjis CG. 1993. Diagnosis and successful treatment of fetal goitrous hyperthyroidism caused by maternal Graves’ disease. Obstetrics and Gynecology 81:837–839.
   PubMedGoogle Scholar
• Huel C, Guibourdenche J, Vuillard E et al. 2009. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound in Obstetrics and Gynecology 33: 412–420.
   PubMed Web of Science ®Google Scholar
• Hume R, Simpson J, Delahunty C et al. 2004. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. Journal of Clinical Endocrinology and Metabolism 89:4097–4103.
   PubMed Web of Science ®Google Scholar
• Kempers MJE, van Tijn DA, van Trotsenburg ASP et al. 2003. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. Journal of Clinical Endocrinology and Metabolism 88:5851–5857.
   PubMedGoogle Scholar
• Lakhwani S, Machado P, Pecos P et al. 2011. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion. Transfusion and Apheresis Science 45:9–11.
   PubMedGoogle Scholar
• Laurberg P, Nygaard B, Glinoer D et al. 1998. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. European Journal of Endocrinology 139:584–586.
   PubMed Web of Science ®Google Scholar
• Laurberg P, Wallin G, Tallstedt L et al. 2008. TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. European Journal of Endocrinology 158:69–75.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Weiner S. 1986. Assessment of fetal growth. Clinics in Perinatology 13:3–35.
   PubMed Web of Science ®Google Scholar
• Luton D, Le Gac I, Vuillard E et al. 2005. Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. Journal of Clinical Endocrinology and Metabolism 90:6093–6098.
   PubMed Web of Science ®Google Scholar
• Matsuura N, Konishi J, Fujieda K et al. 1988. TSH-receptor antibodies in mothers with Graves’ disease and outcome in their offspring. Lancet 1:14–17.
   PubMedGoogle Scholar
• McKenzie JM. 1964. Neonatal Graves’ disease. Journal of Clinical Endocrinology 24:660–668.
   Google Scholar
• Mitsuda N, Tamaki H, Amino N et al. 1992. Risk factors for developmental disorders in infants born to women with Graves disease. Obstetrics and Gynecology 80:359–364.
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh JY, Oyanagi H et al. 1986. Antithyroid drug therapy for Graves’ disease during pregnancy: optimal regimen for fetal thyroid status. New England Journal of Medicine 315:24–28.
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh JY, Ishikawa N et al. 1997. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 82:3633–3636.
   PubMed Web of Science ®Google Scholar
• Mortimer RH, Cannell GR, Addison RS et al. 1997. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. Journal of Clinical Endocrinology and Metabolism 82: 3099–3102.
   PubMed Web of Science ®Google Scholar
• Nachum Z, Rakover Y, Weiner E et al. 2003. Graves’ disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. American Journal of Obstetrics and Gynecology 189:159–165.
   PubMed Web of Science ®Google Scholar
• Page DV, Brady K, Mitchell J et al. 1988. The pathology of intrauterine thyrotoxicosis: two case reports. Obstetrics and Gynecology 72:479–481.
   PubMedGoogle Scholar
• Paladini D, Chita SK, Allan LD. 1990. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Archives of Disease in Childhood 65:20–23.
   PubMed Web of Science ®Google Scholar
• Patil-Sisodia K, Mestman JH. 2010. Graves hyperthyroidism and pregnancy: a clinical update. Endocrine Practice 16:118–129.
   PubMed Web of Science ®Google Scholar
• Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T et al. 2001. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clinical Endocrinology 54:365–370.
   PubMed Web of Science ®Google Scholar
• Radaelli T, Cetin I, Zamperini P et al. 2002. Intrauterine growth of normal thyroid. Gynecological Endocrinology 16:427–430.
   PubMed Web of Science ®Google Scholar
• Ranzini AC, Ananth CV, Smulian JC et al. 2001. Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. Journal of Ultrasound in Medicine 20:613–617.
   PubMed Web of Science ®Google Scholar
• Rapaport R, Rose SR, Freemark M. 2001. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. Journal of Pediatrics 139:182–188.
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Yazdy MM, Carmichael SL et al. 2007. Maternal thyroid disease as a risk factor for craniosynostosis. Obstetrics and Gynecology 110:369–377.
   PubMedGoogle Scholar
• Srisupundit K, Sirichotiyakul S, Tongprasert F et al. 2008. Fetal therapy in fetal thyrotoxicosis: a case report. Fetal Diagnosis and Therapy 23: 114–116.
   PubMedGoogle Scholar
• Stagnaro-Green A, Abalovich M, Alexander E et al. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21: 1081–1125.
   PubMed Web of Science ®Google Scholar
• Tamaki H, Amino N, Takeoka K et al. 1989. Prediction of later development of thyrotoxicosis or central hypothyroidism from the cord serum thyroid-stimulating hormone level in neonates born to mothers with Graves disease. Journal of Pediatrics 115:318–321.
   PubMedGoogle Scholar
• Treadwell MC, Sherer DM, Sacks AJ et al. 1996. Successful treatment of recurrent non-immune hydrops secondary to fetal hyperthyroidism. Obstetrics and Gynecology 87:838–840.
   PubMed Web of Science ®Google Scholar
• Vulsma T, Gons MH, de Vijlder JJM. 1989. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. New England Journal of Medicine 321: 13–16.
   PubMed Web of Science ®Google Scholar
• Wallace C, Couch R, Ginsberg J. 1995. Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, treatment. Thyroid 5:125–128.
   PubMedGoogle Scholar
• Wenstrom KD, Weiner CP, Williamson RA et al. 1990. Prenatal diagnosis of fetal hyperthyroidism using funipuncture. Obstetrics and Gynecology 76:513–517.
   PubMedGoogle Scholar
• Wing DA, Millar LK, Koonings PP et al. 1994. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. American Journal of Obstetrics and Gynecology 170: 90–95.
   PubMed Web of Science ®Google Scholar
• Zakaraija M, McKenzie JM, Hoffman WH. 1986. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 62:368–371.
   PubMedGoogle Scholar
• Zuppa AA, Sindico P, Savarese I et al. 2007. Neonatal hyperthyroidism: neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy. Journal of Pediatric Endocrinology and Metabolism 20:535–539.
   PubMedGoogle Scholar
• Zwaveling-Soonawala N, van Trotsenburg P, Vulsma T. 2009. Central hypothyroidism in an infant born to an adequately treated mother with Graves’ disease: an effect of maternally derived thyrotropin receptor antibodies?Thyroid 19:661–662.
   PubMedGoogle Scholar